{"id":18056,"date":"2021-12-02T09:22:33","date_gmt":"2021-12-02T17:22:33","guid":{"rendered":"https:\/\/marketdepth.com\/?p=18056"},"modified":"2021-12-02T09:22:34","modified_gmt":"2021-12-02T17:22:34","slug":"biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/","title":{"rendered":"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol"},"content":{"rendered":"\n

Biofrontera Inc.<\/strong> (NASDAQ: BFRI) shares spiked more than 35% after the biopharmaceutical\u00a0company announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17\/234,490, titled \u201cIllumination for Photodynamic Therapy,\u201d that covers an innovative, pain-reducing illumination protocol for photodynamic therapy (PDT).<\/p>\n\n\n\n

\u201cThis patented illumination protocol demonstrates Biofrontera\u2019s commitment to the patients\u2019 need for innovative treatments. The patent also strengthens Biofrontera\u2019s competitiveness for our FDA-approved combination product, Ameluz\u00ae together with our PDT-lamp BF-RhodoLED\u00ae and its successor model RhodoLED\u00ae XL in the U.S. by providing an opportunity to pursue label expansion to include more patient-friendly protocols.\u201d<\/p>Erica Monaco, Chief Executive Officer of Biofrontera Inc.<\/cite><\/blockquote>\n\n\n\n

The patent application claims a method for photodynamic therapy in which a dynamic and innovative illumination protocol is implemented. This protocol consists of changing illumination intensities combined in a predefined order with interruptions of the illumination to specifically modulate and reduce pain perception to the patient. The new illumination protocol aims at combining the high efficacy of Ameluz\u00ae with the flexibility of BF-RhodoLED\u00ae to modulate light for pain reduction to ultimately become a new standard-of-care in PDT.<\/p>\n\n\n\n

Therapies for Skin Diseases<\/h5>\n\n\n\n

Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"Biofrontera Inc. (NASDAQ: BFRI) shares spiked more than 35% after the biopharmaceutical\u00a0company announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17\/234,490, titled \u201cIllumination for Photodynamic Therapy,\u201d that covers an innovative, pain-reducing illumination protocol for photodynamic therapy (PDT). \u201cThis patented illumination protocol… View Article<\/a>","protected":false},"author":3,"featured_media":17835,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[9,31,17,11,16],"tags":[],"acf":[],"yoast_head":"\nBiofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"Biofrontera Inc. (NASDAQ: BFRI) shares spiked more than 35% after the biopharmaceutical\u00a0company announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17\/234,490, titled \u201cIllumination for Photodynamic Therapy,\u201d that covers an innovative, pain-reducing illumination protocol for photodynamic therapy (PDT). \u201cThis patented illumination protocol... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-02T17:22:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-02T17:22:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/11\/StockJumps.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol\",\"datePublished\":\"2021-12-02T17:22:33+00:00\",\"dateModified\":\"2021-12-02T17:22:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\"},\"wordCount\":237,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Biotechnology\",\"Business\",\"Headlines\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\",\"url\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\",\"name\":\"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2021-12-02T17:22:33+00:00\",\"dateModified\":\"2021-12-02T17:22:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News & Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/","og_locale":"en_US","og_type":"article","og_title":"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol - MarketDepth","og_description":"Biofrontera Inc. (NASDAQ: BFRI) shares spiked more than 35% after the biopharmaceutical\u00a0company announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17\/234,490, titled \u201cIllumination for Photodynamic Therapy,\u201d that covers an innovative, pain-reducing illumination protocol for photodynamic therapy (PDT). \u201cThis patented illumination protocol... View Article","og_url":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2021-12-02T17:22:33+00:00","article_modified_time":"2021-12-02T17:22:34+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/11\/StockJumps.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol","datePublished":"2021-12-02T17:22:33+00:00","dateModified":"2021-12-02T17:22:34+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/"},"wordCount":237,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Biotechnology","Business","Headlines","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/","url":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/","name":"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2021-12-02T17:22:33+00:00","dateModified":"2021-12-02T17:22:34+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/biofrontera-stock-rises-after-allowance-for-u-s-patent-on-innovative-illumination-protocol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"Biofrontera Stock Rises After Allowance for U.S. Patent on Innovative Illumination Protocol"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News & Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18056"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=18056"}],"version-history":[{"count":1,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18056\/revisions"}],"predecessor-version":[{"id":18057,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18056\/revisions\/18057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/17835"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=18056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=18056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=18056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}